首页|黄卡瓦胡椒素B下调雄激素受体对三阴性乳腺癌增殖和迁移的影响

黄卡瓦胡椒素B下调雄激素受体对三阴性乳腺癌增殖和迁移的影响

扫码查看
目的 探讨黄卡瓦胡椒素B(FKB)下调雄激素受体(AR)对三阴性乳腺癌(TNBC)细胞增殖和迁移的影响。方法 基于GEPIA2数据库分析乳腺癌组织及正常乳腺组织中AR的表达情况。采用Western blotting检测6种乳腺癌细胞系(SUM159PT、MCF-7、T47D、BT474、Hs-578T和MDB-MA-231)中雌激素受体(ER)、人表皮生长因子受体2(HER2)、孕激素受体(PR)和AR蛋白的表达情况。在正常或雄激素剥夺条件下,使用CCK-8法检测不同浓度(0、10、20、30、40、50、60 μmoL/L)FKB处理不同时间(24、48、72 h)对SUM159PT细胞增殖活性的影响。利用30 μmoL/L FKB处理SUM159PT细胞0、4和8 h后,采用qRT-PCR和Western blotting检测AR mRNA及蛋白的表达情况。在雄激素剥夺的条件下,取SUM159PT细胞设置对照组(0。1%DMSO处理)、二氢睾酮(DHT)组(10 nmol/L DHT处理)、FKB组(15 μmol/L FKB处理)、DHT+FKB组(10 nmol/L DHT+15 μmol/L FKB处理)、恩杂鲁胺(ENZA)组(40 μmol/L ENZA处理)及DHT+ENZA组(10 nmol/L DHT+40 μmol/L ENZA处理)。采用CCK-8法、Transwell实验和克隆形成实验检测各组细胞增殖、迁移和克隆形成能力,Western blotting检测各组上皮-间质转化(EMT)相关蛋白(N-cadherin、Occludin、Vimentin)及AR蛋白的表达水平。结果 乳腺癌组织中AR mRNA表达水平明显高于正常乳腺组织(P<0。05)。除MDB-MA-231外,AR在其他5种乳腺癌细胞系(SUM159PT、MCF-7、T47D、BT474和Hs-578T)中均有表达。FKB可下调SUM159PT细胞中AR mRNA和蛋白表达水平(P<0。001)。Western blotting检测结果显示,DHT可诱导SUM159PT细胞中AR蛋白表达水平上调,而FKB抑制DHT诱导的AR蛋白表达水平上调(P<0。01)。FKB和ENZA均抑制SUM159PT细胞的增殖和迁移能力,并逆转DHT诱导的细胞增殖和迁移能力增加(P<0。05)。FKB和ENZA均可降低N-cadherin和Vimentin蛋白表达水平,并逆转DHT诱导的N-cadherin和Vimentin蛋白表达水平上调(P<0。05)。此外,FKB还可增加Occludin蛋白的表达,逆转DHT导致的Occludin蛋白表达降低(P<0。05)。结论 FKB可能通过调节AR的表达抑制TNBC细胞的增殖、迁移以及克隆形成能力,从而抑制TNBC的进展。
Effect of flavokawain B downregulates androgen receptor on the proliferation and migration in triple-negative breast cancer
Objective To investigate how flavokawain B(FKB)affects the proliferation and migration of triple-negative breast cancer(TNBC)cells by downregulating the androgen receptor(AR).Methods The expression of AR in breast cancer and normal tissues was analyzed using the GEPIA2 database.Expression of estrogen receptor(ER),human epidermal growth factor receptor 2(HER2),progesterone receptor(PR),and AR was detected in six breast cancer cell lines(SUM159PT,MCF-7,T47D,BT474,Hs-578T,and MDB-MA-231)by Western blotting.The effect of FKB(0,10,20,30,40,50,60 μmoL/L)treatment of 24,48,and 72 h on the proliferative activity of SUM159PT breast cancer cells was assessed using the CCK-8 assay under normal or androgen deprivation conditions.The mRNA and protein of AR expression was measured by qRT-PCR and Western blotting after 30 μmoL/L FKB treatment of SUM159PT cells for 0,4 and 8 h.SUM159PT cells were set as control group(treatment with 0.1%DMSO),dihydrotestosterone(DHT)group(treatment with 10 nmol/L DHT),FKB group(treatment with 15 μmol/L FKB),DHT+FKB group(treatment with 10 nmol/L DHT and 15 μmol/L FKB),AR antagonist enzalutamide(ENZA)group(treatment with 40 μmol/L ENZA),and DHT+ENZA group(treatment with 10 nmol/L DHT and 40 μmol/L ENZA)under androgen deprivation conditions.Cell proliferation,migration,and colony formation abilities in the above groups were determined using the CCK-8 method,Transwell assay,and clone formation test.Western blotting was also used to detect the expression levels of EMT-related proteins(N-cadherin,Occludin,Vimentin)and AR protein.Results AR mRNA expression level was significantly higher in breast cancer tissue than in normal breast tissue(P<0.05).AR was expressed at comparable levels in five different breast cancer cell lines(SUM159PT,MCF-7,T47D,BT474,and Hs-578T)in addition to MDB-MA-231.FKB can downregulate AR mRNA and protein levels(P<0.05).Western blotting results showed that DHT could upregulate AR protein levels in SUM159PT cells,but FKB could prevent the DHT-induced upregulation of AR protein levels(P<0.05).FKB and ENZA decreased SUM159PT cell proliferation and migration and DHT-mediated cell proliferation and migration(P<0.05).FKB and ENZA can reduce N-cadherin and Vimentin protein levels and counteract DHT-induced increases in N-cadherin and Vimentin protein levels(P<0.05).In addition,FKB may increase Occludin expression and counteract the DHT-induced decrease in Occludin protein expression(P<0.05).Conclusion Flavokawain B could inhibit the proliferation,migration,and clonogenic ability of TNBC cells by regulating AR expression.

androgen receptorflavokawain Btriple-negative breast cancer

杨忠云、吴婷、李雪森

展开 >

西南医科大学基础医学院肿瘤医学研究所,四川泸州 646000

雄激素受体 黄卡瓦胡椒素B 三阴性乳腺癌

四川省科技计划联合创新专项

2022YFS0623

2024

解放军医学杂志
人民军医出版社

解放军医学杂志

CSTPCD北大核心
影响因子:1.644
ISSN:0577-7402
年,卷(期):2024.49(8)